The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BoE Stimuli Push Up Stocks But Depress Sterling

Thu, 04th Aug 2016 16:04

LONDON (Alliance News) - Stocks in London ended firmly in the green Thursday, while the pound took a big hit, after the Bank of England announced a substantial package of stimuli including an interest rate cut to a new record low and an expansion in asset purchases, after recent macroeconomic data had pointed to a slowdown in the UK economy following the Brexit referendum.

The BoE also drastically downgraded its growth projections as the Leave vote heightened uncertainty and the sharp depreciation in sterling triggered an upward revision to the inflation forecast.

The Monetary Policy Committee voted unanimously to cut UK interest rates by 25 basis points to 0.25%, the first rate cut since 2009. Governor Mark Carney said in a press conference following the decision that there is room for further cuts to rates, but made it clear that they will not go as low as to become negative.

"I'm not a fan of negative rate interest rates," Carney said, speaking to journalists. The governor signalled that the lower bound of rates will be close to zero, but always "a positive number".

Alongside the cut to rates, the central bank expanded the size of its Asset Purchase Facility programme, with the increase totalling GBP170 billion as a whole. Purchases of UK government bonds will increase by GBP60 billion to GBP435 billion. This measure was passed after the MPC voted 6-3, with policymakers Kristin Forbes, Ian McCafferty, and Martin Weale against the proposition, preferring no change.

The MPC also decided on the purchase of up to GBP10 billion of UK corporate bonds, with the decision approved with 8-1 majority.

In addition, the MPC voted unanimously to introduce a Term Funding Scheme that will be financed by the issuance of central bank reserves, aimed to help reinforce the transmission of the interest rate cut to the real economy. The BoE said this will operate as part of the asset purchasing programme.

The value of the lending in the TFS will be determined by usage of the scheme, the bank said, and could reach "around GBP100 billion". Carney added that UK banks have "no excuse" not to pass on the rate cut.

The governor said that, at this meeting, "everyone in the MPC though this economy needed stimulus". Carney noted that the Leave vote in the referendum represents a "regime change", but said the UK is "one of the most flexible economies in the world".

Oanda senior market analyst Craig Erlam said that, with this decision, "the BoE became one of the only central banks to announce a stimulus package that appears to have, at least for now, exceeded market expectations and satisfy investors in a way that other central banks have failed this year."

According to the Inflation Report released alongside the monetary policy decision, the economy is likely to see little growth in the second half of 2016. Business investment is set to continue to fall in the near term on slower demand growth. Gross domestic product growth is forecast to ease to 0.1% in the third quarter of 2016. The bank slashed its GDP growth outlook for 2017 to 0.8% from 2.3%. Similarly, the projection for 2018 was trimmed to 1.8% from 2.3%.

The fall in sterling is set to push up inflation in the near-term. Inflation is forecast to return to the 2% target in late 2017 and overshoot this target throughout 2018.

Sterling dropped immediately after the BoE's decision, having being quoted at USD1.3316 just prior. At the London equities close, the pound stood at 1.3138, compared to USD1.3327 at the same time Wednesday. The currency, however, remained way above the 31-year low of USD1.2797 reached in early July, with the results of the EU referendum still fresh.

Contrary to the pound, London stocks shot higher after the BoE decision, with the FTSE 100 index ending up 1.6%, or 105.76 points, at 6,740.16. The FTSE 250 of mid-caps rose 1.5%, or 247.19 points, to 17,244.32, and the AIM All-Share added 0.6%, or 4.33 points, to end at 761.66.

Aviva ended as the biggest blue-chip gainer, up 6.7%. The insurer's chief executive told journalists he is unsure about what an interest rate cut in the UK will achieve, after the blue-chip insurer had posted higher operating profit and hiked its dividend on a strong first half for its life and fund management businesses.

Aviva CEO Mark Wilson, speaking before the BoE's decision, said there is not currently a large amount of household debt in the UK and borrowing rates are already "incredibly cheap". Wilson was sanguine when questioned about any impact Aviva could face from interest rates remaining low or, indeed, falling further.

He said Aviva has been structured to ensure liabilities and assets move together, adding the group has "deliberately positioned" itself as a "blue-chip haven" against low interest rates.

Aviva declared an interim dividend of 7.42p, up from 6.75p a year prior, driven by strong performances in its life insurance and fund management operations. It said it remains on track to deliver on its plan to increase its dividend payout ratio to 50% of operating earnings per share by the end of 2017 from 42% in 2015.

RSA Insurance also reported first-half results, delivering a big rise in underwriting profit and declaring an increase in dividend. Underwriting profit for the first half increased 63% to GBP119.0 million from GBP73.0 million. This was driven by a 3.1 percentage point improvement in RSA's attritional loss ratio to 54.8% from 57.9%. The group declared an interim dividend of 5.0 pence per share, up 43% from 3.5p a year prior. RSA shares rose 1.4%.

Shares in Standard Chartered added 4.3% after Standard & Poor's Global upgraded the lender to Hold from Sell, while HSBC Holdings rose 2.5% after Merrill Lynch lifted its recommendation on the bank to Buy from Underperform, according to traders.

Hikma Pharmaceuticals missed the gains, ending as by far the worst blue-chip performer, down 17%. The drug company late Wednesday said it expects full-year operating profit within its Generics division to be hit by changes in revenue mix, but maintained its guidance on its other two divisions.

The company noted that it had experienced some delays in certain product approvals, but said the impact to revenue should be offset by higher contract manufacturing revenue. However, Hikma said the change in revenue mix is expected to hit profitability in 2016, along with higher than expected costs resulting from the acceleration in timing of certain pipeline-related litigation.

Hikma said it now expects core operating profit within its Generics division to come in within the range of USD30.0 million and USD40.0 million for 2016, below the USD46.0 million reported for 2015. Hikma was downgraded to Neutral from Buy by Citigroup and to Hold from Add by Numis.

In mainland Europe, the CAC 40 index in Paris the DAX 30 in Frankfurt both added 0.6%. At the equities close, the euro was quoted at USD1.1134, compared to USD1.1175 at the same time Wednesday.

In New York, stocks were higher at the European equities close, with the Dow 30 flat, and the S&P and the Nasdaq Composite both up 0.1%.

Gold was quoted at USD1.363.19 an ounce at the equities close, against USD1,357.14 on Wednesday, while Brent oil stood at USD43.30 a barrel, compared to USD42.47 on Wednesday.

Highlights in the economic calendar Friday are UK Halifax house prices at 0830 BST, and US nonfarm payrolls at 1330 BST. The US Baker Hughes US oil rig count is at 1800 BST.

In the UK corporate calendar, Royal Bank of Scotland Group, Ibstock, William Hill, Esure Group, and Kennedy Wilson Europe Real Estate all report half-year results. Bellway and S&U issue trading statements.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2023 09:39

LONDON BROKER RATINGS: Jefferies raises John Wood to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
3 Aug 2023 15:45

UK dividends calendar - next 7 days

Friday 4 August 
Burberry Group PLCdividend payment date
Bytes Technology Group PLCdividend payment date
Bytes Technology Group PLCspecial dividend payment date
CC Japan Income & Growth Trust PLCdividend payment date
CT UK High Income Trust PLCdividend payment date
Ferguson PLCdividend payment date
Global Smaller Cos Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan European Discovery Trust PLCdividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Mitie Group PLCdividend payment date
NewRiver REIT PLCdividend payment date
Norcros PLCdividend payment date
North American Income Trust PLCdividend payment date
Palace Capital PLCdividend payment date
Premier Miton Group PLCdividend payment date
Regional REIT Ltddividend payment date
Schroder UK Mid Cap Fund PLCdividend payment date
Supermarket Income REIT PLCdividend payment date
Twentyfour Income Fund Ltddividend payment date
Value & Indexed Property Income Trust PLCdividend payment date
Vodafone Group PLCdividend payment date
Vp PLCdividend payment date
Workspace Group PLCdividend payment date
Monday 7 August 
no events scheduled 
Tuesday 8 August 
no events scheduled 
Wednesday 9 August 
National Grid PLCdividend payment date
Record PLCdividend payment date
Thursday 10 August 
abrdn New Dawn Investment Trust PLCex-dividend payment date
Alternative Income REIT PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
Avon Protection PLCex-dividend payment date
Barclays PLCex-dividend payment date
BP PLCex-dividend payment date
Domino's Pizza Group PLCex-dividend payment date
Fresnillo PLCex-dividend payment date
Greencoat Renewables PLCex-dividend payment date
Greencoat UK Wind PLCex-dividend payment date
Halfords Group PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
HSBC Holdings PLCex-dividend payment date
IMI PLCex-dividend payment date
Impax Environmental Markets PLCex-dividend payment date
Informa PLCex-dividend payment date
IP Group PLCex-dividend payment date
Irish Residential Properties REIT PLCex-dividend payment date
Lindsell Train Investment Trust PLCex-dividend payment date
LMS Capital PLCex-dividend payment date
Majedie Investments PLCex-dividend payment date
Man Group PLCex-dividend payment date
NatWest Group PLCex-dividend payment date
PayPoint PLCex-dividend payment date
Pearson PLCex-dividend payment date
PRS REIT PLCex-dividend payment date
Quartix Technologies PLCex-dividend payment date
Reach PLCex-dividend payment date
Residential Secure Income PLCex-dividend payment date
Rio Tinto PLCex-dividend payment date
Safestore Holdings PLCdividend payment date
Scottish American Investment Co PLCex-dividend payment date
Segro PLCex-dividend payment date
Shell PLCex-dividend payment date
Speedy Hire PLCex-dividend payment date
Spirent Communications PLCex-dividend payment date
Standard Chartered PLCex-dividend payment date
Target Healthcare REIT PLCex-dividend payment date
Taylor Maritime Investments Ltdex-dividend payment date
Treatt PLCdividend payment date
Tritax Big Box REIT PLCex-dividend payment date
Vanquis Banking Group PLCex-dividend payment date
Vh Global Sustainable Energy Opportunities PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Aug 2023 09:28

Hikma posts higher interim revenue; ups guidance for Generics business

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it expects a higher full year performance from its Generics business amid interim revenue growth, but reported a drop in profit.

Read more
3 Aug 2023 07:51

Hikma lifts guidance for generics business

(Sharecast News) - Hikma Pharmaceuticals lifted annual revenue and margin guidance for its generics business as first-half core operating profit rose 35%.

Read more
27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Friday 28 July 
AstraZeneca PLCHalf Year Results
AIB Group PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Rightmove PLCHalf Year Results
Standard Chartered PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
Vanquis Banking Group PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Bank of Ireland Group PLCHalf Year Results
GlobalData PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Ricardo PLCTrading Statement
Senior PLCHalf Year Results
Spectris PLCHalf Year Results
Tuesday 1 August 
BP PLCHalf Year Results
Coats Group PLCHalf Year Results
Diageo PLCFull Year Results
Domino's Pizza Group PLCHalf Year Results
Filtronic PLCFull Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Metro Bank PLCHalf Year Results
NWF Group PLCFull Year Results
Robert Walters PLCHalf Year Results
Staffline Group PLCHalf Year Results
System1 Group PLCFull Year Results
Travis Perkins PLCHalf Year Results
Virgin Wines UK PLCTrading Statement
Weir Group PLCHalf Year Results
XP Power LtdHalf Year Results
Wednesday 2 August 
BAE Systems PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Haleon PLCHalf Year Results
Genel Energy PLCHalf Year Results
Ibstock PLCHalf Year Results
IP Group PLCHalf Year Results
Kerry Group PLCHalf Year Results
Permanent TSB Group Holdings PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Thursday 3 August 
Coca-Cola Europacific Partners PLCHalf Year Results
Helios Towers PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Mondi PLCTrading Statement
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Omega Diagnostics Group PLCFull Year Results
Pantheon International PLCFull Year Results
Pets At Home Group PLCQ1 Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Serco Group PLCHalf Year Results
Shaftesbury Capital PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Walker Crips Group PLCFull Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 17:08

Commodity-heavy FTSE 100 lifted by Anglo American, China stimulus hopes

Anglo American shines after production update

*

Read more
20 Jul 2023 11:43

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.

Read more
20 Jul 2023 09:54

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boosted other drugmakers' stock.

Read more
20 Jul 2023 08:53

Hikma surges after tornado damages Pfizer injectables plant

(Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.

Read more
12 Jul 2023 09:27

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
8 Jun 2023 12:03

Director dealings: Hikma non-exec invests, LSE Group share buyback rolls on

(Sharecast News) - Hikma Pharmaceuticals was among those on the list of director buys on Thursday, after a non-executive director added almost £27k worth of shares to his holding.

Read more
22 May 2023 09:23

LONDON BROKER RATINGS: Citigroup cuts Sainsbury to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 May 2023 09:29

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning:

Read more
3 May 2023 16:16

Broker tips: HSBC, Hikma, Pearson

(Sharecast News) - Berenberg upgraded HSBC to 'buy' from 'hold' on Wednesday, keeping the price target at 780p, as it said the bank's return on tangible equity of around 13% and attractive growth potential are undervalued.

Read more
3 May 2023 12:56

RBC Capital lifts Hikma price target, reiterates 'outperform'

(Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.